BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31004236)

  • 21. Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis.
    Faustini F; Simon D; Oliveira I; Kleyer A; Haschka J; Englbrecht M; Cavalcante AR; Kraus S; Tabosa TP; Figueiredo C; Hueber AJ; Kocijan R; Cavallaro A; Schett G; Sticherling M; Rech J
    Ann Rheum Dis; 2016 Dec; 75(12):2068-2074. PubMed ID: 26916344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
    Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
    Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.
    Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F
    Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, inflammatory processes and rheumatoid arthritis.
    Calder PC
    Proc Nutr Soc; 2008 Nov; 67(4):409-18. PubMed ID: 18847518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index.
    Maejima H; Taniguchi T; Watarai A; Katsuoka K
    Int J Dermatol; 2010 Aug; 49(8):901-6. PubMed ID: 21174373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A targeted lipidomics approach to the study of eicosanoid release in synovial joints.
    de Grauw JC; van de Lest CH; van Weeren PR
    Arthritis Res Ther; 2011 Jul; 13(4):R123. PubMed ID: 21794148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.
    Szentpetery A; Heffernan E; Gogarty M; Mellerick L; McCormack J; Haroon M; Elmamoun M; Gallagher P; Kelly G; Fabre A; Kirby B; FitzGerald O
    Arthritis Res Ther; 2017 Jul; 19(1):158. PubMed ID: 28679449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
    Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
    Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis.
    Wenink MH; Santegoets KC; Butcher J; van Bon L; Lamers-Karnebeek FG; van den Berg WB; van Riel PL; McInnes IB; Radstake TR
    Arthritis Rheum; 2011 Nov; 63(11):3313-22. PubMed ID: 21811995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review on the role of eicosanoid pathways in rheumatoid arthritis.
    Hoxha M
    Adv Med Sci; 2018 Mar; 63(1):22-29. PubMed ID: 28818745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Proteome and Eicosanoid Profiling Approach for Revealing Implications of Human Fibroblasts in Chronic Inflammation.
    Tahir A; Bileck A; Muqaku B; Niederstaetter L; Kreutz D; Mayer RL; Wolrab D; Meier SM; Slany A; Gerner C
    Anal Chem; 2017 Feb; 89(3):1945-1954. PubMed ID: 28208246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease.
    Husni ME; Wilson Tang WH; Lucke M; Chandrasekharan UM; Brennan DM; Hazen SL
    Arthritis Rheumatol; 2018 Aug; 70(8):1240-1250. PubMed ID: 29569857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic metabolomic analysis of eicosanoids after omega-3 polyunsaturated fatty acid supplementation by a highly specific liquid chromatography-tandem mass spectrometry-based method.
    Zhang X; Yang N; Ai D; Zhu Y
    J Proteome Res; 2015 Apr; 14(4):1843-53. PubMed ID: 25736083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study.
    Klingberg E; Bilberg A; Björkman S; Hedberg M; Jacobsson L; Forsblad-d'Elia H; Carlsten H; Eliasson B; Larsson I
    Arthritis Res Ther; 2019 Jan; 21(1):17. PubMed ID: 30635024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPLC/MS/MS-based approaches for detection and quantification of eicosanoids.
    Lundström SL; D'Alexandri FL; Nithipatikom K; Haeggström JZ; Wheelock AM; Wheelock CE
    Methods Mol Biol; 2009; 579():161-87. PubMed ID: 19763475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study.
    Love TJ; Gudjonsson JE; Valdimarsson H; Gudbjornsson B
    Scand J Rheumatol; 2010 Aug; 39(4):299-302. PubMed ID: 20476857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the changes in eicosanoid profiles of activated macrophages treated with 20(S)-ginsenoside Rg3.
    Lee JW; Choi YR; Mok HJ; Seong HA; Lee DY; Kim GS; Yoon JH; Kim KP; Kim HD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():14-19. PubMed ID: 28938131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.
    Korotaeva TV; Loginova EY; Getiya TS; Nasonov EL
    Ter Arkh; 2018 May; 90(5):22-29. PubMed ID: 30701886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.